Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Curcumin  COVID-19 treatment studies for Curcumin  C19 studies: Curcumin  Curcumin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia
Chabot et al., Cureus, doi:10.7759/cureus.17829
Chabot et al., Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia, Cureus, doi:10.7759/cureus.17829
Sep 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Small case study of 2 patients, showing significant improvement in taste and smell shortly after one dose of a turmeric supplement. Authors note that the risk of one dose is low in healthy individuals not on medications metabolized by cytochromes P450, and the potential benefit is high.
Chabot et al., 8 Sep 2021, peer-reviewed, 2 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperCurcuminAll
Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia
A Bert Chabot, Margaret P Huntwork
Cureus, doi:10.7759/cureus.17829
The coronavirus disease 2019 (COVID-19) pandemic has caused a calamitous perturbation of society worldwide. Anosmia and ageusia (or hyposmia and dysgeusia) have been recognized as two common expressions of COVID-19 infection that linger for days to weeks, and in rare cases are thought to be immutable. Time alone has hitherto proven most effective in their restoration, but turmeric, long believed by some to have medicinal properties, may be a swifter and surer alleviator of anosmia and ageusia. This case series reports the speedy and consequential restoration of taste and smell in two subjects infected with COVID-19 following ingestion of one 1000 mg dose of a turmeric supplement. In view of this, we propose that turmeric be considered in the treatment of anosmia and ageusia caused by COVID-19 infection.
Additional Information Disclosures Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services
References
Brann, Tsukahara, Weinreb, Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia, Sci Adv, doi:10.1101/2020.03.25.009084
Das, Sarmah, Lyndem, Roy, An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study, J Biomol Struct Dyn, doi:10.1080/07391102.2020.1763201
Hay, Lucariello, Contieri, Esposito, Luca et al., Therapeutic effects of turmeric in several diseases: an overview, Chem Biol Interact, doi:10.1016/j.cbi.2019.108729
Jena, Kanungo, Nayak, Chainy, Dandapat, Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies, Sci Rep, doi:10.1038/s41598-021-81462-7
Lee, Lee, Wee, Kim, Prognosis of postviral olfactory loss: follow-up study for longer than one year, Am J Rhinol Allergy, doi:10.2500/ajra.2014.28.4102
Meinhardt, Radke, Dittmayer, Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19, Nat Neurosci, doi:10.1038/s41593-020-00758-5
Paderno, Mattavelli, Rampinelli, Olfactory and gustatory outcomes in COVID-19: a prospective evaluation in nonhospitalized subjects, Otolaryngol Head Neck Surg, doi:10.1177/0194599820939538
Soleimani, Sahebkar, Hosseinzadeh, Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review, Phyt other Res, doi:10.1002/ptr.6054
Vaira, Salzano, Fois, Piombino, Riu, Potential pathogenesis of ageusia and anosmia in COVID-19 patients, Int Forum Allergy Rhinol, doi:10.1002/alr.22593
Whitcroft, Hummel, Olfactory dysfunction in COVID-19: diagnosis and management, JAMA, doi:10.1001/jama.2020.8391
White, Pasupuleti, Roman, Li, Hernandez, Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials, Pharmacol Res, doi:10.1016/j.phrs.2019.104280
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit